|
HNRNPD expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.032900E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.47240000034377E-07 |
| Normal-vs-Stage2 |
1.145390E-01 |
| Normal-vs-Stage3 |
1.896020E-01 |
| Normal-vs-Stage4 |
8.686300E-02 |
| Stage1-vs-Stage2 |
5.612400E-02 |
| Stage1-vs-Stage3 |
2.185000E-04 |
| Stage1-vs-Stage4 |
5.956300E-03 |
| Stage2-vs-Stage3 |
4.858400E-01 |
| Stage2-vs-Stage4 |
7.838400E-01 |
| Stage3-vs-Stage4 |
6.217400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.449200E-04 |
| Normal-vs-AfricanAmerican |
2.783900E-03 |
| Normal-vs-Asian |
4.005800E-01 |
| Caucasian-vs-AfricanAmerican |
5.220400E-01 |
| Caucasian-vs-Asian |
7.179200E-01 |
| AfricanAmerican-vs-Asian |
5.502800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.158600E-03 |
| Normal-vs-Female |
1.12320000000832E-06 |
| Male-vs-Female |
1.536490E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.158000E-02 |
| Normal-vs-Age(41-60Yrs) |
8.43919999999887E-05 |
| Normal-vs-Age(61-80Yrs) |
3.182400E-03 |
| Normal-vs-Age(81-100Yrs) |
9.821600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.764000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.700400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.289220E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.070600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.599600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.565700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.09319999719304E-08 |
| Normal-vs-Grade 2 |
2.39520000500093E-08 |
| Normal-vs-Grade 3 |
1.046440E-01 |
| Normal-vs-Grade 4 |
8.727200E-01 |
| Grade 1-vs-Grade 2 |
6.160500E-03 |
| Grade 1-vs-Grade 3 |
1.27729999999104E-06 |
| Grade 1-vs-Grade 4 |
4.83550000041078E-07 |
| Grade 2-vs-Grade 3 |
5.21729999980458E-07 |
| Grade 2-vs-Grade 4 |
9.43510000017689E-07 |
| Grade 3-vs-Grade 4 |
1.565350E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
7.33839655708834E-11 |
| Normal-vs-ccB subtype |
7.318800E-01 |
| ccA subtype-vs-ccB subtype |
3.32289751270309E-13 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.443300E-03 |
| Normal-vs-N1 |
5.118200E-01 |
| N0-vs-N1 |
5.956200E-02 |
|
|
